nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—IRX4—salivary gland cancer	0.12	0.138	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—SLC25A3—salivary gland cancer	0.0831	0.0953	CbGpPWpGaD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—ISL1—salivary gland cancer	0.0728	0.0835	CbGpPWpGaD
Ezetimibe—ANPEP—Peptide hormone metabolism—ISL1—salivary gland cancer	0.0499	0.0572	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—SMARCA2—salivary gland cancer	0.0345	0.0396	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—MYB—salivary gland cancer	0.0241	0.0277	CbGpPWpGaD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—salivary gland cancer	0.0185	0.0212	CbGpPWpGaD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—NSD1—salivary gland cancer	0.0157	0.018	CbGpPWpGaD
Ezetimibe—SOAT1—parotid gland—salivary gland cancer	0.0144	0.113	CbGeAlD
Ezetimibe—ANPEP—Cardiac Progenitor Differentiation—NOTCH1—salivary gland cancer	0.0142	0.0163	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0139	0.016	CbGpPWpGaD
Ezetimibe—SOAT1—saliva-secreting gland—salivary gland cancer	0.0138	0.108	CbGeAlD
Ezetimibe—ANPEP—parotid gland—salivary gland cancer	0.0138	0.108	CbGeAlD
Ezetimibe—UGT1A3—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.0135	0.0155	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.0134	0.0154	CbGpPWpGaD
Ezetimibe—ANPEP—saliva-secreting gland—salivary gland cancer	0.0132	0.103	CbGeAlD
Ezetimibe—SOAT1—connective tissue—salivary gland cancer	0.0127	0.099	CbGeAlD
Ezetimibe—ANPEP—connective tissue—salivary gland cancer	0.0121	0.0947	CbGeAlD
Ezetimibe—ANPEP—epithelium—salivary gland cancer	0.0115	0.0899	CbGeAlD
Ezetimibe—ABCC3—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.0115	0.0132	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCL11A—salivary gland cancer	0.00998	0.0114	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—ISL1—salivary gland cancer	0.00942	0.0108	CbGpPWpGaD
Ezetimibe—UGT1A1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00932	0.0107	CbGpPWpGaD
Ezetimibe—ABCC2—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00909	0.0104	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—CREBBP—salivary gland cancer	0.0089	0.0102	CbGpPWpGaD
Ezetimibe—ANPEP—lymphoid tissue—salivary gland cancer	0.00886	0.0693	CbGeAlD
Ezetimibe—ANPEP—Metabolism of proteins—IGFBP2—salivary gland cancer	0.00852	0.00977	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—NSD1—salivary gland cancer	0.00848	0.00973	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—GAS6—salivary gland cancer	0.00759	0.00871	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ISYNA1—salivary gland cancer	0.00733	0.00841	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—CCND1—salivary gland cancer	0.00658	0.00755	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00641	0.00734	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00617	0.00707	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—EP300—salivary gland cancer	0.00606	0.00695	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—MARCKS—salivary gland cancer	0.00598	0.00685	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—ST3GAL4—salivary gland cancer	0.00596	0.00683	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ISYNA1—salivary gland cancer	0.00556	0.00637	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PYGB—salivary gland cancer	0.00556	0.00637	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ISYNA1—salivary gland cancer	0.00535	0.00613	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC24A3—salivary gland cancer	0.00524	0.00601	CbGpPWpGaD
Ezetimibe—SOAT1—lymph node—salivary gland cancer	0.00523	0.0409	CbGeAlD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00508	0.00582	CbGpPWpGaD
Ezetimibe—ANPEP—lymph node—salivary gland cancer	0.005	0.0391	CbGeAlD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00489	0.00561	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—MARCKS—salivary gland cancer	0.00453	0.00519	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PHGDH—salivary gland cancer	0.00453	0.00519	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—MARCKS—salivary gland cancer	0.00436	0.005	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ST3GAL4—salivary gland cancer	0.00436	0.005	CbGpPWpGaD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.0043	0.00493	CbGpPWpGaD
Ezetimibe—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00428	0.0049	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PYGB—salivary gland cancer	0.00421	0.00483	CbGpPWpGaD
Ezetimibe—ANPEP—C-MYB transcription factor network—HRAS—salivary gland cancer	0.00415	0.00476	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PYGB—salivary gland cancer	0.00405	0.00465	CbGpPWpGaD
Ezetimibe—ABCG2—parotid gland—salivary gland cancer	0.004	0.0313	CbGeAlD
Ezetimibe—NPC1L1—Metabolism—AQP1—salivary gland cancer	0.00396	0.00454	CbGpPWpGaD
Ezetimibe—ABCG2—saliva-secreting gland—salivary gland cancer	0.00383	0.0299	CbGeAlD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00358	0.0041	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—CREBBP—salivary gland cancer	0.00349	0.004	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PHGDH—salivary gland cancer	0.00343	0.00394	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ST3GAL4—salivary gland cancer	0.0033	0.00379	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PHGDH—salivary gland cancer	0.0033	0.00379	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—FBXW7—salivary gland cancer	0.00325	0.00373	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.00318	0.00365	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ST3GAL4—salivary gland cancer	0.00318	0.00365	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—NUP62—salivary gland cancer	0.00314	0.0036	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ISYNA1—salivary gland cancer	0.00313	0.00359	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—VCAN—salivary gland cancer	0.00311	0.00357	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—AQP1—salivary gland cancer	0.003	0.00344	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—AQP1—salivary gland cancer	0.00289	0.00331	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00284	0.00325	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.00273	0.00313	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00266	0.00306	CbGpPWpGaD
Ezetimibe—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00263	0.00302	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—MARCKS—salivary gland cancer	0.00255	0.00292	CbGpPWpGaD
Ezetimibe—ABCC3—Fluoropyrimidine Activity—TP53—salivary gland cancer	0.00253	0.0029	CbGpPWpGaD
Ezetimibe—ABCC3—lymph node—salivary gland cancer	0.00249	0.0195	CbGeAlD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00247	0.00283	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—NUP62—salivary gland cancer	0.00238	0.00273	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-2-alpha transcription factor network—EP300—salivary gland cancer	0.00238	0.00273	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PYGB—salivary gland cancer	0.00237	0.00272	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—VCAN—salivary gland cancer	0.00236	0.00271	CbGpPWpGaD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.00232	0.00266	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—NUP62—salivary gland cancer	0.00229	0.00263	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—VCAN—salivary gland cancer	0.00227	0.00261	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.0022	0.00252	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.00207	0.00238	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.00205	0.00235	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.00199	0.00229	CbGpPWpGaD
Ezetimibe—ABCC2—lymph node—salivary gland cancer	0.00199	0.0156	CbGeAlD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00197	0.00226	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.00195	0.00224	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PHGDH—salivary gland cancer	0.00193	0.00222	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—NUP62—salivary gland cancer	0.00191	0.00219	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.0019	0.00217	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00186	0.00213	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ST3GAL4—salivary gland cancer	0.00186	0.00213	CbGpPWpGaD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—salivary gland cancer	0.00174	0.002	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AQP1—salivary gland cancer	0.00169	0.00194	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ISYNA1—salivary gland cancer	0.00168	0.00192	CbGpPWpGaD
Ezetimibe—ABCB1—epithelium—salivary gland cancer	0.00165	0.0129	CbGeAlD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00164	0.00188	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.00148	0.0017	CbGpPWpGaD
Ezetimibe—ABCG2—lymph node—salivary gland cancer	0.00145	0.0113	CbGeAlD
Ezetimibe—ABCC3—Metabolism—ISYNA1—salivary gland cancer	0.00143	0.00163	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ISYNA1—salivary gland cancer	0.00143	0.00163	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.00142	0.00163	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00141	0.00162	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.0014	0.0016	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.00138	0.00158	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MARCKS—salivary gland cancer	0.00137	0.00157	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00136	0.00156	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—NUP62—salivary gland cancer	0.00134	0.00154	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00133	0.00153	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—VCAN—salivary gland cancer	0.00133	0.00152	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.0013	0.00149	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.0013	0.00149	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PYGB—salivary gland cancer	0.00127	0.00146	CbGpPWpGaD
Ezetimibe—ABCB1—lymphoid tissue—salivary gland cancer	0.00127	0.00992	CbGeAlD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00122	0.0014	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—CREBBP—salivary gland cancer	0.00122	0.0014	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MARCKS—salivary gland cancer	0.00116	0.00133	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MARCKS—salivary gland cancer	0.00116	0.00133	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ISYNA1—salivary gland cancer	0.00116	0.00133	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.00113	0.0013	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.00111	0.00127	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PYGB—salivary gland cancer	0.00108	0.00124	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PYGB—salivary gland cancer	0.00108	0.00124	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ISYNA1—salivary gland cancer	0.00106	0.00122	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.00104	0.0012	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PHGDH—salivary gland cancer	0.00104	0.00119	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00103	0.00118	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00101	0.00116	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.001	0.00115	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ST3GAL4—salivary gland cancer	0.000997	0.00114	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ISYNA1—salivary gland cancer	0.000983	0.00113	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.00097	0.00111	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MARCKS—salivary gland cancer	0.000944	0.00108	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CREBBP—salivary gland cancer	0.000922	0.00106	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AQP1—salivary gland cancer	0.000905	0.00104	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000898	0.00103	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CREBBP—salivary gland cancer	0.000888	0.00102	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PHGDH—salivary gland cancer	0.00088	0.00101	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PHGDH—salivary gland cancer	0.00088	0.00101	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PYGB—salivary gland cancer	0.000878	0.00101	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTEN—salivary gland cancer	0.000869	0.000997	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MARCKS—salivary gland cancer	0.000865	0.000992	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ST3GAL4—salivary gland cancer	0.000848	0.000972	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ST3GAL4—salivary gland cancer	0.000848	0.000972	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—EP300—salivary gland cancer	0.000829	0.000951	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00081	0.000929	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PYGB—salivary gland cancer	0.000804	0.000922	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MARCKS—salivary gland cancer	0.000801	0.000918	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AQP1—salivary gland cancer	0.00077	0.000882	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AQP1—salivary gland cancer	0.00077	0.000882	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.000756	0.000867	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PYGB—salivary gland cancer	0.000745	0.000854	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NUP62—salivary gland cancer	0.000718	0.000823	CbGpPWpGaD
Ezetimibe—ABCB1—lymph node—salivary gland cancer	0.000716	0.0056	CbGeAlD
Ezetimibe—UGT1A1—Metabolism—PHGDH—salivary gland cancer	0.000715	0.00082	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—VCAN—salivary gland cancer	0.000712	0.000817	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ST3GAL4—salivary gland cancer	0.000689	0.00079	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTEN—salivary gland cancer	0.000659	0.000755	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PHGDH—salivary gland cancer	0.000656	0.000752	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTEN—salivary gland cancer	0.000634	0.000727	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ST3GAL4—salivary gland cancer	0.000631	0.000724	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—EP300—salivary gland cancer	0.000628	0.00072	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AQP1—salivary gland cancer	0.000625	0.000717	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PIK3CA—salivary gland cancer	0.000613	0.000703	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000613	0.000702	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NUP62—salivary gland cancer	0.00061	0.0007	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NUP62—salivary gland cancer	0.00061	0.0007	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PHGDH—salivary gland cancer	0.000607	0.000696	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—VCAN—salivary gland cancer	0.000605	0.000694	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—VCAN—salivary gland cancer	0.000605	0.000694	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—EP300—salivary gland cancer	0.000605	0.000693	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ST3GAL4—salivary gland cancer	0.000584	0.00067	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AQP1—salivary gland cancer	0.000573	0.000657	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000546	0.000626	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000531	0.000609	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000531	0.000609	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AQP1—salivary gland cancer	0.000531	0.000608	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CREBBP—salivary gland cancer	0.00052	0.000596	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000505	0.000579	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NUP62—salivary gland cancer	0.000496	0.000569	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—VCAN—salivary gland cancer	0.000492	0.000564	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000486	0.000557	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000474	0.000544	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PIK3CA—salivary gland cancer	0.000465	0.000533	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NUP62—salivary gland cancer	0.000454	0.000521	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—VCAN—salivary gland cancer	0.000451	0.000517	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PIK3CA—salivary gland cancer	0.000447	0.000513	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000433	0.000497	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NUP62—salivary gland cancer	0.000421	0.000482	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—VCAN—salivary gland cancer	0.000417	0.000479	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000403	0.000462	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000401	0.000459	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000396	0.000454	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000379	0.000435	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000376	0.000431	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTEN—salivary gland cancer	0.000371	0.000425	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000362	0.000415	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—EP300—salivary gland cancer	0.000354	0.000406	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000351	0.000402	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000348	0.000399	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000339	0.000388	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000328	0.000376	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000327	0.000375	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000323	0.00037	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000316	0.000362	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000287	0.000329	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000283	0.000324	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CREBBP—salivary gland cancer	0.000278	0.000319	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000269	0.000309	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000268	0.000307	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000267	0.000306	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CA—salivary gland cancer	0.000262	0.0003	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000248	0.000284	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000239	0.000274	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CREBBP—salivary gland cancer	0.000237	0.000271	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CREBBP—salivary gland cancer	0.000237	0.000271	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000231	0.000265	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000227	0.000261	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000226	0.000259	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000202	0.000232	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000199	0.000229	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTEN—salivary gland cancer	0.000199	0.000228	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000195	0.000223	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CREBBP—salivary gland cancer	0.000192	0.000221	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—EP300—salivary gland cancer	0.00019	0.000217	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000188	0.000216	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000177	0.000203	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CREBBP—salivary gland cancer	0.000176	0.000202	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTEN—salivary gland cancer	0.000169	0.000194	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTEN—salivary gland cancer	0.000169	0.000194	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CREBBP—salivary gland cancer	0.000163	0.000187	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—EP300—salivary gland cancer	0.000161	0.000185	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—EP300—salivary gland cancer	0.000161	0.000185	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CA—salivary gland cancer	0.00014	0.000161	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.00014	0.000161	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000139	0.000159	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTEN—salivary gland cancer	0.000137	0.000157	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—EP300—salivary gland cancer	0.000131	0.00015	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTEN—salivary gland cancer	0.000126	0.000144	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—EP300—salivary gland cancer	0.00012	0.000138	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CA—salivary gland cancer	0.000119	0.000137	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CA—salivary gland cancer	0.000119	0.000137	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTEN—salivary gland cancer	0.000117	0.000134	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—EP300—salivary gland cancer	0.000111	0.000127	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CA—salivary gland cancer	9.69e-05	0.000111	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CA—salivary gland cancer	8.88e-05	0.000102	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CREBBP—salivary gland cancer	8.82e-05	0.000101	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CA—salivary gland cancer	8.22e-05	9.43e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTEN—salivary gland cancer	6.3e-05	7.22e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—EP300—salivary gland cancer	6.01e-05	6.89e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CREBBP—salivary gland cancer	5.44e-05	6.23e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CA—salivary gland cancer	4.44e-05	5.1e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTEN—salivary gland cancer	3.88e-05	4.45e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—EP300—salivary gland cancer	3.7e-05	4.24e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	2.74e-05	3.14e-05	CbGpPWpGaD
